Y. C. Kim, J. Y. Y. (2018). A multi-centre, open, investigator initiated phase IV clinical trial to evaluate the efficacy and safety of ingenol mebutate gel, 0.015% on the face and scalp, and 0.05% on the trunk and extremities, in Korean patients with actinic keratosis (PERFECT). Wiley-Blackwell.
Chicago Style (17th ed.) CitationY. C. Kim, J. Y. Yang. A Multi-centre, Open, Investigator Initiated Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Ingenol Mebutate Gel, 0.015% on the Face and Scalp, and 0.05% on the Trunk and Extremities, in Korean Patients with Actinic Keratosis (PERFECT). Wiley-Blackwell, 2018.
MLA (9th ed.) CitationY. C. Kim, J. Y. Yang. A Multi-centre, Open, Investigator Initiated Phase IV Clinical Trial to Evaluate the Efficacy and Safety of Ingenol Mebutate Gel, 0.015% on the Face and Scalp, and 0.05% on the Trunk and Extremities, in Korean Patients with Actinic Keratosis (PERFECT). Wiley-Blackwell, 2018.